Form 8-K - Current report:
SEC Accession No. 0001437749-26-024522
Filing Date
2026-07-27
Accepted
2026-07-27 16:33:24
Documents
14
Period of Report
2026-07-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20260727_8k.htm   iXBRL 8-K 31789
2 EXHIBIT 99.1 ex_993355.htm EX-99.1 114522
7 govxa01.jpg GRAPHIC 5893
  Complete submission text file 0001437749-26-024522.txt   299233

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA govx-20260727.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20260727_def.xml EX-101.DEF 11807
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20260727_lab.xml EX-101.LAB 15858
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20260727_pre.xml EX-101.PRE 12022
17 EXTRACTED XBRL INSTANCE DOCUMENT govx20260727_8k_htm.xml XML 2940
Mailing Address 1955 LAKE PARK DRIVE SUITE 300 SMYRNA GA
Business Address 1955 LAKE PARK DRIVE SUITE 300 SMYRNA GA 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 261206239
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)